SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15479360
Source:
http://linkedlifedata.com/resource/pubmed/id/15479360
Search
Subject
(
62
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0001128
,
umls-concept:C0030705
,
umls-concept:C0042960
,
umls-concept:C0050940
,
umls-concept:C0267055
,
umls-concept:C0348016
,
umls-concept:C0439185
,
umls-concept:C0442027
,
umls-concept:C1549078
,
umls-concept:C1709366
,
umls-concept:C1948023
,
umls-concept:C1997894
pubmed:issue
8
pubmed:dateCreated
2004-10-13
pubmed:abstractText
Some patients requiring acid suppression may be unable to take oral medications.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8707234
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/2-Pyridinylmethylsulfinylbenzimidazo...
,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole
,
http://linkedlifedata.com/resource/pubmed/chemical/lansoprazole
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0269-2813
pubmed:author
pubmed-author:ChiuY-LYL
,
pubmed-author:KovacsT O GTO
,
pubmed-author:LeaC MCM
,
pubmed-author:MetzD CDC
,
pubmed-author:PilmerB LBL
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
883-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15479360-2-Pyridinylmethylsulfinylbenzimidazoles
,
pubmed-meshheading:15479360-Administration, Oral
,
pubmed-meshheading:15479360-Adolescent
,
pubmed-meshheading:15479360-Adult
,
pubmed-meshheading:15479360-Aged
,
pubmed-meshheading:15479360-Anti-Ulcer Agents
,
pubmed-meshheading:15479360-Double-Blind Method
,
pubmed-meshheading:15479360-Esophagitis
,
pubmed-meshheading:15479360-Female
,
pubmed-meshheading:15479360-Gastric Acid
,
pubmed-meshheading:15479360-Humans
,
pubmed-meshheading:15479360-Infusions, Intravenous
,
pubmed-meshheading:15479360-Male
,
pubmed-meshheading:15479360-Middle Aged
,
pubmed-meshheading:15479360-Omeprazole
,
pubmed-meshheading:15479360-Treatment Outcome
pubmed:year
2004
pubmed:articleTitle
Intravenous and oral lansoprazole are equivalent in suppressing stimulated acid output in patient volunteers with erosive oesophagitis.
pubmed:affiliation
VA Greater Los Angeles Healthcare System, CURE Clinic, Los Angeles, CA 90073, USA. tkovacs@mednet.ucla.edu
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study